Finance

Beta
Lists
PM:NYSE
Philip Morris International Inc.
$173.17
-2.93%
(-5.23) 1D
$173.17
0.00% (0.00)
After hours
Closed: Jun 22, 4:00:06 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PM...
Open
$178.05
High
$178.89
Low
$172.29
Mkt. cap
269.90B
Avg. vol.
5.07M
Volume
4.49M
Dividend
3.40%
Quarterly dividend
$1.47
Ex-dividend date
Jun 25, 2026
P/E ratio
24.39
52-wk high
$193.05
52-wk low
$142.11
EPS
$7.10
Beta
0.38
Shares outstanding
1.56B
No. of employees
85K
Open
$178.05
High
$178.89
Low
$172.29
Mkt. cap
269.90B
Avg. vol.
5.07M
Volume
4.49M
Dividend
3.40%
Quarterly dividend
$1.47
Ex-dividend date
Jun 25, 2026
P/E ratio
24.39
52-wk high
$193.05
52-wk low
$142.11
EPS
$7.10
Beta
0.38
Shares outstanding
1.56B
No. of employees
85K
News stories
From sources across the web
Profile
Philip Morris International Inc. is a tobacco company, with products sold in over 180 countries. Marlboro is PMI’s most recognized brand, but in the last quarter of 2023, Iqos generated the greatest revenue. Philip Morris International is often referred to as one of the companies comprising Big Tobacco. The company ranked No. 121 in the 2025 Fortune 500 list of the largest US corporations by total revenue. The company originated in 1847 in London, but Philip Morris International itself was established in 1987 as an operating company of Philip Morris Companies Inc. In 2003, Philip Morris Companies changed its name to Altria Group. In March 2008, PMI was spun off from Altria and has been an entirely separate entity since then. Philip Morris USA, a subsidiary of PMI's former parent, keeps ownership of the Philip Morris brands for the US market. The company's legal seat is in Stamford, Connecticut. PMI's operational headquarters are in Lausanne, Switzerland. With tobacco being addictive and a leading cause of preventable death globally, the company has faced litigation and regulatory measures from governments and has been the subject of scrutiny by the World Health Organization. Wikipedia
About Philip Morris International Inc.
CEOJacek Olczak
Employees84.9K
Founded1847
HeadquartersStamford, Connecticut, United States
SectorTobacco
Websitepmi.com
Analyst Ratings
Based on 9 analysts giving stock ratings to PM in the past 3 months
Strong Buy
Buy
7
Hold
2
Sell
0
12 month forecast
Based on 9 Wall Street analysts offering 12 month price targets for PM in the last 3 months.
Highest
Current $173.17
$209.00 (+20.69%)
Average
$197.43 (+14.01%)
Lowest
$168.00 (-2.99%)
Analyst
Recommendation
Action
Price Target
Projected
Date
Dara Mohsenian
Morgan Stanley
Buy
Reiterated
$200.00
+15.5%
06/22/2026
Pallav Mittal
Barclays
Buy
Reiterated
$205.00
+18.4%
06/09/2026
Eric Serotta
Morgan Stanley
Buy
Reiterated
$200.00
+15.5%
06/03/2026
Lisa Lewandowski
Bank of America Securities
Buy
Reiterated
$209.00
+20.7%
06/02/2026
Bonnie Herzog
Goldman Sachs
Buy
Reiterated
$205.00
+18.4%
05/20/2026
Callum Elliott
Bernstein
Hold
Maintained
-
-
05/12/2026
Gerald Pascarelli
Needham
Buy
Reiterated
$200.00
+15.5%
04/23/2026
Christine Dooley
Argus Research
Buy
Maintained
-
-
04/22/2026
Matthew Smith, CFA
Stifel Nicolaus
Buy
Reiterated
$195.00
+12.6%
04/23/2026
Faham Baig
UBS
Hold
Reiterated
$168.00
-3%
04/17/2026
Taylor Conrad
Argus Research
Buy
Maintained
$210.00
+21.3%
02/26/2026
Simon Hales
Citi
Buy
Maintained
$210.00
+21.3%
02/10/2026
Last report
Apr 22, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
$1.96 / $1.83
+7.07%beat
Revenue / Est. (USD)
10.15B / 9.91B
+2.41%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
10.14B
10.84B
10.36B
10.15B
Cost of goods sold
3.28B
3.49B
3.56B
3.24B
Cost of revenue
3.28B
3.49B
3.56B
3.24B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.77B
2.94B
3.39B
3.24B
Operating expense
1.78B
2.94B
3.39B
3.25B
Total operating expenses
5.06B
6.43B
6.95B
6.49B
Operating income
5.08B
4.42B
3.41B
3.66B
Other non operating income
-
-
-
-
EBT including unusual items
3.80B
4.36B
2.92B
3.26B
EBT excluding unusual items
4.08B
4.52B
2.81B
3.28B
Income tax expense
652.00M
751.00M
675.00M
676.00M
Effective tax rate
17.16%
17.21%
23.08%
20.75%
Other operating expenses
9.00M
-
-
7.00M
Net income
3.04B
3.48B
2.14B
2.44B
Net profit margin
29.97%
32.07%
20.66%
24.03%
Earnings per share
1.91
2.24
1.70
1.96
Interest and investment income
-
-
621.00M
-
Interest expense
-437.00M
-403.00M
-343.00M
-391.00M
Net interest expenses
-437.00M
-403.00M
278.00M
-391.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
5.57B
4.92B
3.93B
4.17B
Gain or loss from assets sale
-
-
94.00M
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more